成人骨髓增生异常/骨髓增殖性肿瘤的分子图景与克隆结构
该研究对367例成人骨髓增生异常/骨髓增殖性肿瘤(MDS/MPN)患者进行全基因组测序,包括慢性粒单核细胞白血病(CMML)119例、非典型慢性髓系白血病(aCML)71例、伴环形铁粒幼细胞和血小板增多的MDS/MPN(MDS/MPN-RS-T)71例及不能分类的MDS/MPN(MDS/MPN-U)106例。30个基因在≥3%的队列中反复突变,各亚型间突变基因分布和克隆结构存在差异,并发现与特定亚型相关的基因组合及影响预后的特定突变。
要点
- 367例成人MDS/MPN中30个基因反复突变(≥3%),各亚型突变分布与克隆结构不同。
- 特定基因组合与MDS/MPN亚型相关,如CMML中TET2-SRSF2、aCML中ASXL1-SETBP1、MDS/MPN-RS-T中SF3B1-JAK2。
- MDS/MPN-U异质性最大,其分子特征模拟其他亚型并影响患者结局。
核心结论
- 研究结果有助于阐明MDS/MPN的异质性,并可用于MDS/MPN的临床实践。
研究设计与样本
- 对367例成人MDS/MPN患者进行全基因组测序,包括CMML 119例、aCML 71例、MDS/MPN-RS-T 71例和MDS/MPN-U 106例。
主要发现
- 30个基因在≥3%的队列中反复突变。
- 反复突变基因的分布和克隆结构在MDS/MPN各亚型间存在差异。
- 发现与特定MDS/MPN亚型相关的基因组合,且这些组合与大多数其他MDS/MPN互斥,如CMML中TET2-SRSF2、aCML中ASXL1-SETBP1、MDS/MPN-RS-T中SF3B1-JAK2。
- MDS/MPN-U患者异质性最大,其分子谱模拟其他MDS/MPN亚型并影响患者结局。
- 特定基因突变影响不同MDS/MPN亚型的结局。
临床怎么用
- 作者认为特定基因突变对结局的影响可能对临床决策有意义。
- 作者认为研究结果可用于MDS/MPN的临床实践。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
More than 90% of patients with myelodysplastic/myeloproliferative neoplasms (MDSs/MPNs) harbor somatic mutations in myeloid-related genes, but still, current diagnostic criteria do not include molecular data. We performed genome-wide sequencing techniques to characterize the mutational landscape of a large and clinically well-characterized cohort including 367 adults with MDS/MPN subtypes, including chronic myelomonocytic leukemia (CMML; n = 119), atypical chronic myeloid leukemia (aCML; n = 71), MDS/MPN with ring sideroblasts and thrombocytosis (MDS/MPN-RS-T; n = 71), and MDS/MPN unclassifiable (MDS/MPN-U; n = 106). A total of 30 genes were recurrently mutated in ≥3% of the cohort. Distribution of recurrently mutated genes and clonal architecture differed among MDS/MPN subtypes. Statistical analysis revealed significant correlations between recurrently mutated genes, as well as genotype-phenotype associations. We identified specific gene combinations that were associated with distinct MDS/MPN subtypes and that were mutually exclusive with most of the other MDSs/MPNs (eg, TET2-SRSF2 in CMML, ASXL1-SETBP1 in aCML, and SF3B1-JAK2 in MDS/MPN-RS-T). Patients with MDS/MPN-U were the most heterogeneous and displayed different molecular profiles that mimicked the ones observed in other MDS/MPN subtypes and that had an impact on the outcome of the patients. Specific gene mutations also had an impact on the outcome of the different MDS/MPN subtypes, which may be relevant for clinical decision-making. Overall, the results of this study help to elucidate the heterogeneity found in these neoplasms, which can be of use in the clinical setting of MDS/MPN.
引用
- Palomo L, Meggendorfer M, Hutter S, et al. Molecular landscape and clonal architecture of adult myelodysplastic/myeloproliferative neoplasms. Blood. 2020. PMID: 32573691. doi:10.1182/blood.2019004229
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。